Literature DB >> 15838446

Ocular and systemic manifestations of PHACES (Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects and coarctation of the Aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome.

Alaina Kronenberg1, Francine Blei, Emily Ceisler, Mark Steele, Louis Furlan, Sylvia Kodsi.   

Abstract

INTRODUCTION: PHACES syndrome (Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects and coarctation of the aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental defects) is a rare neurocutaneous syndrome with only 2 case reports published in the ophthalmic literature. This study was conducted to identify ocular and systemic manifestations of PHACES syndrome.
METHODS: A retrospective chart review was performed on 8 children with a diagnosis of PHACES syndrome. Information recorded included age at first visit, length of follow-up, gender, race, vision, need for glasses, strabismus, amblyopia, ptosis, proptosis, anterior and posterior segment abnormalities, need for treatment of the hemangioma, type of treatment of the hemangioma, and systemic manifestations.
RESULTS: Periocular and ocular findings in patients with PHACES syndrome included hemangioma involving ocular structures (n = 6), strabismus (n = 4), amblyopia (n = 5), proptosis (n = 2), ptosis (n = 5), anterior polar cataract (n = 1), optic atrophy from optic neuropathy (n = 1), heterochromia (n = 1), and refractive error requiring glasses (n = 2). All patients were treated with steroids for the hemangioma. Systemic manifestations of PHACES syndrome included posterior fossa malformation (n = 4), hemangioma (n = 8), arterial anomalies (n = 3), cardiac abnormalities (n = 3), and sternal or ventral deformities (n = 3).
CONCLUSION: Children with PHACES syndrome may have significant ocular and systemic abnormalities and are at increased risk for strabismus and amblyopia. They often require steroid therapy of the hemangioma to prevent and/or treat ocular complications. These patients require careful monitoring by a pediatric ophthalmologist in addition to other subspecialists.

Entities:  

Mesh:

Year:  2005        PMID: 15838446     DOI: 10.1016/j.jaapos.2004.08.012

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  5 in total

1.  Incidence and clinical characteristics of periocular infantile hemangiomas.

Authors:  Saba T Alniemi; Gregory J Griepentrog; Nancy Diehl; Brian G Mohney
Journal:  Arch Ophthalmol       Date:  2012-07

2.  PHACES syndrome with small, late-onset hemangiomas.

Authors:  Birgin Torer; Hande Gulcan; Hasan Kilicdag; Murat Derbent
Journal:  Eur J Pediatr       Date:  2007-01-12       Impact factor: 3.183

3.  Periocular capillary hemangiomas: indications and options for treatment.

Authors:  Genie M Bang; Pete Setabutr
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations.

Authors:  Raheleh Assari; Vahid Ziaee; Sasan Moghimi; Mohammad Reza Akbari; Arash Mirmohammadsadeghi
Journal:  J Curr Ophthalmol       Date:  2016-12-27

Review 5.  Infantile Periocular Hemangioma.

Authors:  Mehdi Tavakoli; Saeid Yadegari; Mahnaz Mosallaei; Maryam Aletaha; Hossein Salour; Wendy W Lee
Journal:  J Ophthalmic Vis Res       Date:  2017 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.